+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Gilead Sciences Inc - logo

Founded in 1987 Gilead Sciences is a biopharmaceutical company focused on developing innovative treatments for life threatening illnesses. Their areas of research include HIV/AIDs, Liver Diseases, Hematology, Oncology, Cardiovascular and Respiratory disease. Gilead Sciences is based in California, USA and their product portfolio consists of well-known treatments like Atripla, Sovaldi, Zydelig, Viread and many more.

From
From
From
From
Kidney Disease Market Report 2025 - Product Thumbnail Image

Kidney Disease Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
HIV Integrase Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

HIV Integrase Inhibitors - Pipeline Insight, 2025

  • Report
  • April 2025
  • 60 Pages
  • Global
From
Hepatic Encephalopathy Market Report 2025 - Product Thumbnail Image

Hepatic Encephalopathy Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
From
From
From
From
Hepatitis B Therapeutics Market 2024-2028 - Product Thumbnail Image

Hepatitis B Therapeutics Market 2024-2028

  • Report
  • June 2024
  • 141 Pages
  • Global
From
Bone Marrow Transplantation Market Report 2025 - Product Thumbnail Image

Bone Marrow Transplantation Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Loading Indicator